Atrium Therapeutics, Inc. Share Price
NASDAQ: RNA | Small CapAtrium Therapeutics, Inc. Stock Performance
Atrium Therapeutics, Inc. Share Price Today
As of 18 November 2026, Atrium Therapeutics, Inc.'s share price is $6.47. The stock opened at $6.89, compared to its previous close of $6.43. During today's trading session, Atrium Therapeutics, Inc.'s share price traded between $6.45 and $6.94, with an average price of $6.70. Over the past 52 weeks, the stock has recorded a high of $73.05 and a low of $6.38. In terms of performance, Atrium Therapeutics, Inc.'s share price has declined by 50.19% over the last six months and is down 90.98% on a year-on-year basis.
Atrium Therapeutics, Inc. Share Price Chart
Atrium Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Atrium Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Atrium Therapeutics, Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Atrium Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $8.30 | $6.45 | -22.10% |
Oct 2026 | $8.37 | $8.28 | -0.30% |
Sep 2026 | $13.30 | $8.30 | -40.34% |
Aug 2026 | $11.40 | $13.92 | +22.54% |
Jul 2026 | $13.42 | $11.36 | -15.35% |
Jun 2026 | $12.60 | $13.42 | +3.31% |
May 2026 | $13.15 | $12.99 | +1.80% |
Apr 2026 | $13.66 | $12.76 | -4.38% |
Mar 2026 | $14.13 | $13.35 | -9.68% |
Feb 2026 | $72.53 | $14.78 | -79.64% |
Jan 2026 | $72.10 | $72.57 | +0.61% |
Dec 2025 | $71.49 | $72.13 | +0.54% |